• Latest
  • Trending
  • All
  • India
  • Business
  • Politics
  • World
  • Lifestyle
  • Technology
Current anti-COVID pills work well against Omicron, antibody drugs less effective: Study

Current anti-COVID pills work well against Omicron, antibody drugs less effective: Study

January 31, 2022
Dalal Street starts week higher as Sensex jumps over 400 points; IT, banks lead gains

Dalal Street starts week higher as Sensex jumps over 400 points; IT, banks lead gains

November 16, 2026
Breast cancer screening: Mammogram, ultrasound or MRI? Doctor explains which imaging test you need and when

Breast cancer screening: Mammogram, ultrasound or MRI? Doctor explains which imaging test you need and when

November 16, 2026
Scene worldwide box office collection day 9: Suriya's crime comedy overtakes Vishwanath & Sons to become his second highest-grossing film

Scene worldwide box office collection day 9: Suriya’s crime comedy overtakes Vishwanath & Sons to become his second highest-grossing film

November 16, 2026
Trump’s Asia reset: Deals in Manila and Shenzhen, then a rare nuclear summit with Xi and Putin

Trump’s Asia reset: Deals in Manila and Shenzhen, then a rare nuclear summit with Xi and Putin

November 16, 2026
Back in rhythm, Lakshya Sen clinches second title of season

Back in rhythm, Lakshya Sen clinches second title of season

November 16, 2026
From inflammation to blood clots: Understanding how air pollution can raise heart attack risk and what happens inside blood vessels

From inflammation to blood clots: Understanding how air pollution can raise heart attack risk and what happens inside blood vessels

November 12, 2026
Delhi AQI worsens to 323, IIT-Delhi records severe air quality as farm fires persist

Delhi AQI worsens to 323, IIT-Delhi records severe air quality as farm fires persist

November 12, 2026
Sensex, Nifty rally on falling crude, FII buying after a day's break

Sensex, Nifty rally on falling crude, FII buying after a day’s break

November 11, 2026
Has the Diwali celebration affected your lungs? An oncologist reveals everything about the air quality and its adverse health effects

Has the Diwali celebration affected your lungs? An oncologist reveals everything about the air quality and its adverse health effects

November 11, 2026
Maatrubhumi trailer out: Salman Khan heads to the battlefield, takes on Chinese troops with a message of peace

Maatrubhumi trailer out: Salman Khan heads to the battlefield, takes on Chinese troops with a message of peace

November 11, 2026
Six coaches of Kolkata-Sairang Express derail at Digaru railway station in Assam; rescue ops on

Six coaches of Kolkata-Sairang Express derail at Digaru railway station in Assam; rescue ops on

November 11, 2026
Eleven Democrats, seven Republicans did not vote in motion to impeach Defense Secretary Pete Hegseth

Eleven Democrats, seven Republicans did not vote in motion to impeach Defense Secretary Pete Hegseth

November 11, 2026
  • About
  • Advertise
  • Privacy & Policy
  • Contact
Tuesday, November 17, 2026
No Result
View All Result
Daily News Broadcast India
  • India
    • All
    • Politics
    Delhi AQI worsens to 323, IIT-Delhi records severe air quality as farm fires persist

    Delhi AQI worsens to 323, IIT-Delhi records severe air quality as farm fires persist

    Six coaches of Kolkata-Sairang Express derail at Digaru railway station in Assam; rescue ops on

    Six coaches of Kolkata-Sairang Express derail at Digaru railway station in Assam; rescue ops on

    Bengaluru cab driver kills wife, six of his in-laws; arrested: Police

    Bengaluru Cab Driver Kills Wife, Six Of His In-laws; Arrested: Police

    Rahul Gandhi’s ‘alcohol’ remark on Bhagwant Mann sharpens AAP-Congress tussle ahead of Punjab polls

    Rahul Gandhi’s ‘alcohol’ remark on Bhagwant Mann sharpens AAP-Congress tussle ahead of Punjab polls

    Delhi bar body calls for criminal action against suspended ACP for remarks against lawyers

    Delhi bar body calls for criminal action against suspended ACP for remarks against lawyers

    Rahul Gandhi rallies students for ‘Chalo Dilli’ march on November 1

    Rahul Gandhi rallies students for ‘Chalo Dilli’ march on November 1

    Nirmala Sitharaman, Rahul Gandhi spar over Tata leadership dispute: ‘Stop politicising every issue’

    Nirmala Sitharaman, Rahul Gandhi spar over Tata leadership dispute: ‘Stop politicising every issue’

    Uttar Pradesh Legislative Council polls: BJP wins 4, SP 1, ahead on 4 seats

    Uttar Pradesh Legislative Council polls: BJP wins 4, SP 1, ahead on 4 seats

    ‘System auto generated them’: Karnataka poll officials after 61,059 Form 7s filed without specific grounds

    ‘System auto generated them’: Karnataka poll officials after 61,059 Form 7s filed without specific grounds

    Class 3 student crushed by reversing school van Uttar Pradesh's Naini

    Class 3 student crushed by reversing school van Uttar Pradesh’s Naini

    Trending Tags

    • Politics
  • Entertainment
    Scene worldwide box office collection day 9: Suriya's crime comedy overtakes Vishwanath & Sons to become his second highest-grossing film

    Scene worldwide box office collection day 9: Suriya’s crime comedy overtakes Vishwanath & Sons to become his second highest-grossing film

    Maatrubhumi trailer out: Salman Khan heads to the battlefield, takes on Chinese troops with a message of peace

    Maatrubhumi trailer out: Salman Khan heads to the battlefield, takes on Chinese troops with a message of peace

    ‘Maatrubhumi’ trailer: Salman Khan leads 200 Indian soldiers against a sea of Chinese troops in war actioner

    ‘Maatrubhumi’ trailer: Salman Khan leads 200 Indian soldiers against a sea of Chinese troops in war actioner

    Shah Rukh Khan admits struggling to remember Ed Sheeran's lyrics in King song Tu Mil Jaaye, praises daughter Suhana Khan for her effortless lip-sync

    Shah Rukh Khan admits struggling to remember Ed Sheeran’s lyrics in King song Tu Mil Jaaye, praises daughter Suhana Khan for her effortless lip-sync

    Jailer 2 box office collection day 21: Rajinikanth film slows down ahead of Ramayana release, earns ₹466 crore in 3 weeks

    Jailer 2 box office collection day 21: Rajinikanth film slows down ahead of Ramayana release, earns ₹466 crore in 3 weeks

    Suriya asks Lokesh Kanagaraj to call him to discuss stand-alone Rolex movie at Scene event; says he has played too many heroes

    Suriya asks Lokesh Kanagaraj to call him to discuss stand-alone Rolex movie at Scene event; says he has played too many heroes

    Jailer 2 box office collection day 19: Rajinikanth's film slows down, earns its lowest single-day haul on 3rd Monday

    Jailer 2 box office collection day 19: Rajinikanth’s film slows down, earns its lowest single-day haul on 3rd Monday

    Jailer 2 worldwide box office: Rajinikanth, 75, delivers Tamil cinema's first ₹800-crore blockbuster; film beats Chhaava, PK lifetime hauls

    Jailer 2 worldwide box office: Rajinikanth, 75, delivers Tamil cinema’s first ₹800-crore blockbuster; film beats Chhaava, PK lifetime hauls

    Jailer 2 box office collection day 15: Rajinikanth film dips further at the end of second week, earns just ₹5 crore

    Jailer 2 box office collection day 15: Rajinikanth film dips further at the end of second week, earns just ₹5 crore

    ‘Jailer 2’: How singer MS Krsna landed a song with Rajinikanth and Anirudh

    ‘Jailer 2’: How singer MS Krsna landed a song with Rajinikanth and Anirudh

  • Lifestyle
  • Sports
  • Business
  • Technology
  • World
  • Videos
  • Covid19
  • Opinion
DNB india
No Result
View All Result
Home Covid19

Current anti-COVID pills work well against Omicron, antibody drugs less effective: Study

by DNB ind News Desk
January 31, 2022
in Covid19
0
Current anti-COVID pills work well against Omicron, antibody drugs less effective: Study
1
SHARES
4
VIEWS
Share on FacebookShare on TwitterShare to Whatspp

If the ability of the antiviral pills to combat Omicron is confirmed in human patients, it would be welcome news.

Current anti-COVID pills work well against Omicron, antibody drugs less effective: Study

Wisconsin: A new study has found the drugs behind the new pills to treat COVID-19 remain very effective against the Omicron variant of the virus in lab tests. The research has been published in the ‘New England Journal of Medicine’. However, lab tests also showed that the available antibody therapies — typically given intravenously in hospitals — are substantially less effective against Omicron than against earlier variants of the virus.

Some antibodies have entirely lost their ability to neutralize Omicron at realistic dosages.

If the ability of the antiviral pills to combat Omicron is confirmed in human patients, it would be welcome news.

Public health officials expect the pills to become an increasingly common treatment for COVID-19 that will reduce the severity of the disease in at-risk patients and decrease the burden of the pandemic. For now, the pills remain in short supply during the current Omicron wave, which has broken case records in the U.S. and other countries.

The findings corroborated other studies that showed that most available antibody treatments are less effective against Omicron.

Drug makers could design, test and produce new antibody drugs targeted at the Omicron variant to overcome the limitations of current therapies, but this process would take months.

“The bottom line is we have countermeasures to treat Omicron. That’s good news,” says Yoshihiro Kawaoka, the University of Wisconsin-Madison lead of the study and virologist at the UW School of Veterinary Medicine and the University of Tokyo.

“However, this is all in laboratory studies. Whether this translates into humans, we don`t know yet,” Kawaoka added.

The clinically available pills and antibodies were designed and tested before researchers identified the Omicron variant, which differs significantly from earlier versions of the virus.

When Omicron was identified, scientists feared that these differences, caused by mutations in the viral genome, might reduce the effectiveness of drugs designed to treat the original version of the virus.

In lab experiments using non-human primate cells, Kawaoka’s team tested a suite of antibody and antiviral therapies against the original strain of the COVID-19 virus and its prominent variants, including the alpha, delta and Omicron strains.

Merck’s pill molnupiravir and the intravenous drug remdesivir were just as effective against the omicron variant as they were against earlier viral strains.Instead of testing Pfizer’s Paxlovid pill, which is designed to be taken orally, the team tested a related drug by Pfizer that is given intravenously.

The two drugs disrupt the same part of the viral machinery. The researchers found that the intravenous form of the drug retained its effectiveness against Omicron, and this version is currently in clinical trials.All four antibody treatments the researchers tested were less effective against omicron than against earlier strains of the virus.

Two treatments, sotrovimab by GlaxoSmithKline and Evusheld by AstraZeneca, retained some ability to neutralize the virus. However, they required anywhere from 3 to 100 times more of the drugs to neutralize omicron compared to earlier versions.

AstraZeneca’s antibodies are not approved for use in the U.S.Two antibody treatments by Lilly and Regeneron were unable to neutralize omicron at common dosages.

These findings are expected given how the omicron variant differs from earlier strains of SARS-CoV-2, the COVID-19 virus.

Omicron has dozens of mutations in the spike protein, which the virus uses to enter and infect cells. Most antibodies were designed to bind to and neutralize the original spike protein and major changes to the protein can make antibodies less likely to attach to it.In contrast, the antiviral pills target the molecular machinery the virus uses to make copies of itself inside cells.

The Omicron variant only has a few changes to this machinery, which makes it more likely that drugs will retain their ability to disrupt this replication process.

The Kawaoka lab is now studying new antibody candidates to identify ones that could neutralize the omicron variant.This work was supported in part the National Institutes of Healthand the Department of Defense. The study was also supported by the Japan Research Program on Emerging and Reemerging Infectious Diseases , a Project Promoting Support for Drug Discovery, the Japan Program for Infectious Diseases Research and Infrastructure, and a Grant-in-Aid for Emerging and Reemerging Infectious Diseases from the Ministry of Health, Labor, and Welfare, Japan.

Related

Tags: anti-COVID pillscoronaviruscovid-19New England Journal of Medicineomicron variant
ShareTweetSend
DNB ind News Desk

DNB ind News Desk

  • Trending
  • Comments
  • Latest
Yamaha MT-15 V2.0 launched in India, priced at Rs 1.60 lakh

Yamaha MT-15 V2.0 launched in India, priced at Rs 1.60 lakh

April 12, 2022
Shilpa Shetty to Tejasswi Prakash, These Stars Live Life Queen Size

Shilpa Shetty to Tejasswi Prakash, These Stars Live Life Queen Size

April 15, 2022
Saina Nehwal’s CWG and Asian Games title defense under threat due to THIS reason

Saina Nehwal’s CWG and Asian Games title defense under threat due to THIS reason

April 12, 2022

COVID-19 update: India records 7,579 new cases, 236 deaths in last 24 hours

0

Team India vice-captain Cheteshwar Pujara to carry ‘fearless mindset’ from England into NZ Tests

0

Breaking: Andhra Pradesh Assembly passes resolution, asks Centre for caste-based census of backward classes

0
Dalal Street starts week higher as Sensex jumps over 400 points; IT, banks lead gains

Dalal Street starts week higher as Sensex jumps over 400 points; IT, banks lead gains

November 16, 2026
Breast cancer screening: Mammogram, ultrasound or MRI? Doctor explains which imaging test you need and when

Breast cancer screening: Mammogram, ultrasound or MRI? Doctor explains which imaging test you need and when

November 16, 2026
Scene worldwide box office collection day 9: Suriya's crime comedy overtakes Vishwanath & Sons to become his second highest-grossing film

Scene worldwide box office collection day 9: Suriya’s crime comedy overtakes Vishwanath & Sons to become his second highest-grossing film

November 16, 2026
Daily News Broadcast India

Copyright © 2023 Daily News Broadcast India.

Navigate Site

  • About
  • Advertise
  • Privacy & Policy
  • Contact

Follow Us

No Result
View All Result
  • Home
  • India
    • Politics
    • Business
    • World
  • Entertainment
    • Sports
  • Covid19
  • Business
  • Technology
  • Lifestyle

Copyright © 2023 Daily News Broadcast India.

Are you sure want to unlock this post?
Unlock left : 0
Are you sure want to cancel subscription?